Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q3 2025

Type / Class
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share.
Symbol
BNR on Nasdaq
Shares outstanding
9,041,375
Price per share
$21.70
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,420,998
Total reported value
$12,337,668
% of total 13F portfolios
0%
Share change
-14,764
Value change
+$172,458
Number of holders
15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CRCM LP 5.4% $5,963,583 486,426 CRCM LP 16 Dec 2025

As of 30 Sep 2025, 15 institutional investors reported holding 1,420,998 shares of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR). This represents 16% of the company’s total 9,041,375 outstanding shares.

Top 18 Institutional Shareholders

The largest institutional shareholders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) together control 16% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Kynam Capital Management, LP 11% 994,883 0% 0.64% $8,605,738
CRCM LP 2.5% 221,575 +14% 0.55% $1,916,624
Sumitomo Mitsui Trust Group, Inc. 0.39% 34,842 -21% 0% $301,383
Amova Asset Management Americas, Inc. 0.39% 34,842 -21% 0% $314,275
RENAISSANCE TECHNOLOGIES LLC 0.35% 31,717 0% 0% $274,352
BANK OF AMERICA CORP /DE/ 0.32% 29,178 -0.34% 0% $252,390
Prospera Financial Services Inc 0.27% 24,755 0% $214,127
MORGAN STANLEY 0.25% 22,267 +22% 0% $192,610
HSG Holding Ltd 0.23% 21,212 0% 0.01% $215,302
China Universal Asset Management Co., Ltd. 0.03% 3,000 0% $25,950
BNP PARIBAS FINANCIAL MARKETS 0.01% 900 0% 0% $7,785
SHEN NEIL NANPENG 0.01% 885 0% 10% $8,983
UBS Group AG 0.01% 868 +22% 0% $7,508
JPMORGAN CHASE & CO 0% 64 +25% 0% $554
BlackRock, Inc. 0% 10 0% 0% $87
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0% 0 -100% $0
CITADEL ADVISORS LLC 0% 0 -100% $0
RHUMBLINE ADVISERS 0% 0 -100% $0

Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 1,420,998 $12,337,668 +$172,458 $8.65 15
2025 Q2 1,445,762 $4,571,204 -$2,836,549 $3.16 17
2025 Q1 2,204,546 $9,648,455 -$654,410 $4.50 18
2024 Q4 2,344,607 $15,838,361 +$2,155,649 $6.75 21
2024 Q3 2,025,359 $6,615,771 -$63,267 $3.27 16
2024 Q2 2,034,289 $13,034,824 +$13,034,824 $6.45 16